Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Non-comparative Study to Assess the Efficacy, the Safety and the Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea Syndrome in European Population

NCT03510403 is registered in ClinicalTrials.gov with Seven Dreamers Europe SAS as lead sponsor.

NCT NCT03510403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03510403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Non-comparative Study to Assess the Efficacy, the Safety and the Acceptability of Nastent™ in Snoring and Obstructive Sleep Apnea Syndrome in European Population
Lead sponsor
Seven Dreamers Europe SAS
Phase
Not applicable
Overall status
Completed
Start date
April 12, 2018
Completion date
July 25, 2019
Enrollment
32 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea, snoring